TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer

Yohei Sekino, Xiangrui Han, Takafumi Kawaguchi, Takashi Babasaki, Keisuke Goto, Shogo Inoue, Tetsutaro Hayashi, Jun Teishima, Masaki Shiota, Wataru Yasui, Akio Matsubara

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Recent studies have reported that TUBB3 overexpression is involved in docetaxel (DTX) resistance in prostate cancer (PCa). The aim of this study was to clarify the role of TUBB3 in DTX and cabazitaxel (CBZ) resistance, and cross-resistance between DTX and CBZ in PCa. We analyzed the effect of TUBB3 knockdown on DTX and CBZ resistance and examined the interaction between TUBB3 and PTEN. We also investigated the role of phosphoinositide 3-kinases (PI3K) inhibitor (LY294002) in DTX and CBZ resistance. TUBB3 expression was upregulated in DTX-resistant and CBZ-resistant cells. TUBB3 knockdown re-sensitized DTX-resistant cells to DTX and CBZ-resistant cells to CBZ. Additionally, TUBB3 knockdown re-sensitized DTX-resistant cell lines to CBZ, indicating that TUBB3 mediates cross-resistance between DTX and CBZ. Knockdown of TUBB3 enhanced PTEN expression, and PTEN knockout enhanced TUBB3 expression. LY294002 suppressed TUBB3 expression in DTX-resistant and CBZ-resistant cell lines. LY294002 re-sensitized DTX-resistant cell lines to DTX and CBZ-resistant cell lines to CBZ. These results suggest that TUBB3 is involved in DTX resistance and CBZ resistance. A combination of LY294002/DTX and that of LY294002/CBZ could be potential strategies for PCa treatment.

Original languageEnglish
Article number3936
JournalInternational journal of molecular sciences
Volume20
Issue number16
DOIs
Publication statusPublished - Aug 2 2019

Fingerprint

docetaxel
Prostatic Neoplasms
cancer
Cells
cultured cells
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Oncology
cells
Cell Line
cabazitaxel
inhibitors

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Sekino, Y., Han, X., Kawaguchi, T., Babasaki, T., Goto, K., Inoue, S., ... Matsubara, A. (2019). TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer. International journal of molecular sciences, 20(16), [3936]. https://doi.org/10.3390/ijms20163936

TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer. / Sekino, Yohei; Han, Xiangrui; Kawaguchi, Takafumi; Babasaki, Takashi; Goto, Keisuke; Inoue, Shogo; Hayashi, Tetsutaro; Teishima, Jun; Shiota, Masaki; Yasui, Wataru; Matsubara, Akio.

In: International journal of molecular sciences, Vol. 20, No. 16, 3936, 02.08.2019.

Research output: Contribution to journalArticle

Sekino, Y, Han, X, Kawaguchi, T, Babasaki, T, Goto, K, Inoue, S, Hayashi, T, Teishima, J, Shiota, M, Yasui, W & Matsubara, A 2019, 'TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer', International journal of molecular sciences, vol. 20, no. 16, 3936. https://doi.org/10.3390/ijms20163936
Sekino, Yohei ; Han, Xiangrui ; Kawaguchi, Takafumi ; Babasaki, Takashi ; Goto, Keisuke ; Inoue, Shogo ; Hayashi, Tetsutaro ; Teishima, Jun ; Shiota, Masaki ; Yasui, Wataru ; Matsubara, Akio. / TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer. In: International journal of molecular sciences. 2019 ; Vol. 20, No. 16.
@article{2fac32e67ff948d78d4f70907fe2db2f,
title = "TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer",
abstract = "Recent studies have reported that TUBB3 overexpression is involved in docetaxel (DTX) resistance in prostate cancer (PCa). The aim of this study was to clarify the role of TUBB3 in DTX and cabazitaxel (CBZ) resistance, and cross-resistance between DTX and CBZ in PCa. We analyzed the effect of TUBB3 knockdown on DTX and CBZ resistance and examined the interaction between TUBB3 and PTEN. We also investigated the role of phosphoinositide 3-kinases (PI3K) inhibitor (LY294002) in DTX and CBZ resistance. TUBB3 expression was upregulated in DTX-resistant and CBZ-resistant cells. TUBB3 knockdown re-sensitized DTX-resistant cells to DTX and CBZ-resistant cells to CBZ. Additionally, TUBB3 knockdown re-sensitized DTX-resistant cell lines to CBZ, indicating that TUBB3 mediates cross-resistance between DTX and CBZ. Knockdown of TUBB3 enhanced PTEN expression, and PTEN knockout enhanced TUBB3 expression. LY294002 suppressed TUBB3 expression in DTX-resistant and CBZ-resistant cell lines. LY294002 re-sensitized DTX-resistant cell lines to DTX and CBZ-resistant cell lines to CBZ. These results suggest that TUBB3 is involved in DTX resistance and CBZ resistance. A combination of LY294002/DTX and that of LY294002/CBZ could be potential strategies for PCa treatment.",
author = "Yohei Sekino and Xiangrui Han and Takafumi Kawaguchi and Takashi Babasaki and Keisuke Goto and Shogo Inoue and Tetsutaro Hayashi and Jun Teishima and Masaki Shiota and Wataru Yasui and Akio Matsubara",
year = "2019",
month = "8",
day = "2",
doi = "10.3390/ijms20163936",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "16",

}

TY - JOUR

T1 - TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer

AU - Sekino, Yohei

AU - Han, Xiangrui

AU - Kawaguchi, Takafumi

AU - Babasaki, Takashi

AU - Goto, Keisuke

AU - Inoue, Shogo

AU - Hayashi, Tetsutaro

AU - Teishima, Jun

AU - Shiota, Masaki

AU - Yasui, Wataru

AU - Matsubara, Akio

PY - 2019/8/2

Y1 - 2019/8/2

N2 - Recent studies have reported that TUBB3 overexpression is involved in docetaxel (DTX) resistance in prostate cancer (PCa). The aim of this study was to clarify the role of TUBB3 in DTX and cabazitaxel (CBZ) resistance, and cross-resistance between DTX and CBZ in PCa. We analyzed the effect of TUBB3 knockdown on DTX and CBZ resistance and examined the interaction between TUBB3 and PTEN. We also investigated the role of phosphoinositide 3-kinases (PI3K) inhibitor (LY294002) in DTX and CBZ resistance. TUBB3 expression was upregulated in DTX-resistant and CBZ-resistant cells. TUBB3 knockdown re-sensitized DTX-resistant cells to DTX and CBZ-resistant cells to CBZ. Additionally, TUBB3 knockdown re-sensitized DTX-resistant cell lines to CBZ, indicating that TUBB3 mediates cross-resistance between DTX and CBZ. Knockdown of TUBB3 enhanced PTEN expression, and PTEN knockout enhanced TUBB3 expression. LY294002 suppressed TUBB3 expression in DTX-resistant and CBZ-resistant cell lines. LY294002 re-sensitized DTX-resistant cell lines to DTX and CBZ-resistant cell lines to CBZ. These results suggest that TUBB3 is involved in DTX resistance and CBZ resistance. A combination of LY294002/DTX and that of LY294002/CBZ could be potential strategies for PCa treatment.

AB - Recent studies have reported that TUBB3 overexpression is involved in docetaxel (DTX) resistance in prostate cancer (PCa). The aim of this study was to clarify the role of TUBB3 in DTX and cabazitaxel (CBZ) resistance, and cross-resistance between DTX and CBZ in PCa. We analyzed the effect of TUBB3 knockdown on DTX and CBZ resistance and examined the interaction between TUBB3 and PTEN. We also investigated the role of phosphoinositide 3-kinases (PI3K) inhibitor (LY294002) in DTX and CBZ resistance. TUBB3 expression was upregulated in DTX-resistant and CBZ-resistant cells. TUBB3 knockdown re-sensitized DTX-resistant cells to DTX and CBZ-resistant cells to CBZ. Additionally, TUBB3 knockdown re-sensitized DTX-resistant cell lines to CBZ, indicating that TUBB3 mediates cross-resistance between DTX and CBZ. Knockdown of TUBB3 enhanced PTEN expression, and PTEN knockout enhanced TUBB3 expression. LY294002 suppressed TUBB3 expression in DTX-resistant and CBZ-resistant cell lines. LY294002 re-sensitized DTX-resistant cell lines to DTX and CBZ-resistant cell lines to CBZ. These results suggest that TUBB3 is involved in DTX resistance and CBZ resistance. A combination of LY294002/DTX and that of LY294002/CBZ could be potential strategies for PCa treatment.

UR - http://www.scopus.com/inward/record.url?scp=85071280532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071280532&partnerID=8YFLogxK

U2 - 10.3390/ijms20163936

DO - 10.3390/ijms20163936

M3 - Article

C2 - 31412591

AN - SCOPUS:85071280532

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 16

M1 - 3936

ER -